Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for premenstrual dysphoric disorder
IRCT20180604039970N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetylcysteine and fluoxetine in Premenstrual Dysphoric Disorder (PMDD) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Depression score and Daily symptoms score of DRSP. Started May 2017; status: completed.
02
Drugs
acetylcysteinefluoxetine
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on IRCT20180604039970N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180604039970N1.